Moderna, Inc. reports $1.94 billion revenue for fiscal year ended December 31, 2025, down 39.9%

ยท MRNA

Moderna, Inc. reported revenue of $1.94 billion for the year ended December 31, 2025, a decrease of 39.9% from the previous year ($3.24 billion).

For the same period it posted a net loss of $2.82 billion, or $-7.26 per diluted share (-9.28 a year earlier).

That is a net margin of -145.2%.

On Sanad's AAOIFI Standard 21 screen, Moderna, Inc. is currently not compliant: interest-bearing debt is 0.7% of market capitalisation (limit 30%), and impure income is 16.2% of revenue (limit 5%).

Source: 10-K filed with the U.S. Securities and Exchange Commission on February 20, 2026. View the filing. Figures are as reported in the filing. This is information, not investment advice.

More Moderna, Inc. news